ArticleWorld journal of gastroenterology2017

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.

Robert G Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.